{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:39:47Z","timestamp":1783463987360,"version":"3.55.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The incidence of neuroendocrine tumors (NET) has been increasing globally for several decades. The objective of the study was to examine the most recent trend in the incidence of NET as well as disparities by sex and race\/ethnicity in adults in the USA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients with NET aged \u226520\u2009years were identified from the SEER 22 Registries from 2000 to 2020. The age-adjusted incidence rate was calculated for overall NET and by primary site. The incidence trend was assessed by annual percent change. Disparities by sex and race\/ethnicity were examined using the incidence rate ratio.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Age-adjusted incidence rate of overall NET in adults was 9.39 per 100\u2009000 in 2000\u20132020. The incidence rate increased from 2000 but reached a plateau with no significant change since 2015. The lung and bronchus, small intestine, and rectum were the most common primary sites. Sex and racial\/ethnic disparities in NET incidence varied by primary sites. For example, there was a female excess in NET of the lung and bronchus, stomach, and appendix; and there was a male excess in the small intestine, pancreas, colon, rectum and other\/unknown NET. Compared to non-Hispanic white, non-Hispanic black had higher incidences of stomach, small intestine, liver, pancreas, colon, rectum, and other\/unknown NET; they had lower incidences of lung and bronchus, and appendix NET than non-Hispanic white.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Age-adjusted incidence rate of overall NET has reached a plateau since 2015. However, there were sex and racial\/ethnic disparities in such incidence, which varied depending on the primary site of NET.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000877","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T12:01:29Z","timestamp":1708430489000},"page":"475-484","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Incidence trend of neuroendocrine tumors and disparities by sex and race\/ethnicity in adults from the United States, 2000\u20132020"],"prefix":"10.1097","volume":"33","author":[{"given":"Yong","family":"Zhu","sequence":"first","affiliation":[{"name":"Wayzek Science, St Paul, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/erc.0.0110001","article-title":"Neuroendocrine tumours.","volume":"11","author":"Barakat","year":"2004","journal-title":"Endoc Relat Cancer"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"36073","DOI":"10.1038\/srep36073","article-title":"Risk factors for sporadic pancreatic neuroendocrine tumors: a case-control study.","volume":"6","author":"Ben","year":"2016","journal-title":"Sci Rep"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"19245","DOI":"10.18632\/oncotarget.24983","article-title":"Global burden of neuroendocrine tumors and changing incidence in Kentucky.","volume":"9","author":"Chauhan","year":"2018","journal-title":"Oncotarget"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jamaoncol.2019.4568","article-title":"Neuroendocrine tumors\u2014less well known, often misunderstood, and rapidly growing in incidence.","volume":"6","author":"Chauhan","year":"2020","journal-title":"JAMA Oncol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/07370016.2019.1665320","article-title":"Barriers to healthcare access facing American Indian and Alaska Natives in rural America.","volume":"36","author":"Cromer","year":"2019","journal-title":"J Community Health Nurs"},{"key":"R6-20250527","first-page":"268","article-title":"A comprehensive analysis of markers for neuroendocrine tumors of the lungs demonstrates estrogen receptor beta to be a prognostic markers in SCLC male patients.","volume":"5","author":"Curioni-Fontecedro","year":"2014","journal-title":"J Cytol Histol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States.","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"71699","DOI":"10.18632\/oncotarget.17599","article-title":"A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in China.","volume":"8","author":"Fan","year":"2017","journal-title":"Oncotarget"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.04.013","article-title":"Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any?","volume":"67","author":"Gallo","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000375164","article-title":"Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis.","volume":"101","author":"Haugvik","year":"2015","journal-title":"Neuroendocrinology"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America.","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R","article-title":"Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden.","volume":"92","author":"Hemminki","year":"2001","journal-title":"Cancer"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/2767-9764.CRC-22-0093","article-title":"Under-representation of racial groups in genomics studies of gastroenteropancreatic neuroendocrine neoplasms.","volume":"2","author":"Herring","year":"2022","journal-title":"Cancer Res Commun"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"113384","DOI":"10.1016\/j.socscimed.2020.113384","article-title":"Producing insecurity: healthcare access, health insurance, and wellbeing among American Indian elders.","volume":"268","author":"Jaramillo","year":"2021","journal-title":"Soc Sci Med"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjsurg.2022.09.053","article-title":"Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine.","volume":"225","author":"Keller","year":"2023","journal-title":"Am J Surg"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MPA.0000000000001707","article-title":"Racial differences in gastroenteropancreatic neuroendocrine tumor treatment and survival in the United States.","volume":"50","author":"Kessel","year":"2021","journal-title":"Pancreas"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12902-022-01016-4","article-title":"Epidemiology of neuroendocrine neoplasmas in Japan: based on analysis of hospital-based cancer registry data, 2009\u20132015.","volume":"22","author":"Koizumi","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.ejca.2012.12.022","article-title":"Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry.","volume":"49","author":"Korse","year":"2013","journal-title":"Eur J Cancer"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jnci\/djad086","article-title":"Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic.","volume":"115","author":"Mariotto","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors.","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: a review of neuroendocrine tumors and carcinomas.","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"R24-20250527","first-page":"342","article-title":"Culture and colorectal cancer screening on three American Indian reservations.","volume":"21","author":"Perdue","year":"2011","journal-title":"Ethn Dis"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/cancers13081753","article-title":"Incidence and survival outcomes in patients with lung neuroendocrine neoplasms in the United States.","volume":"13","author":"Shah","year":"2021","journal-title":"Cancers"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/MPA.0000000000001431","article-title":"Racial differences in the incidence and survival of patients with neuroendocrine tumors.","volume":"48","author":"Shen","year":"2019","journal-title":"Pancreas"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00001648-200301000-00013","article-title":"Why do Black Americans have a higher risk of pancreatic cancer than White Americans?","volume":"14","author":"Silverman","year":"2003","journal-title":"Epidemiology"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.3390\/nu14194178","article-title":"Trends in diet quality by race\/ethnicity among adults in the United States for 2011\u20132018.","volume":"14","author":"Tao","year":"2022","journal-title":"Nutrients"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"e2231480","DOI":"10.1001\/jamanetworkopen.2022.31480","article-title":"Association between smoking, smoking cessation, and mortality by race, ethnicity, and sex among US adults.","volume":"5","author":"Thomson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"100510","DOI":"10.1016\/j.lanepe.2022.100510","article-title":"Incidence and survival of neuroendocrine neoplasia in England 1995\u20132018: a retrospective, population-based study.","volume":"23","author":"White","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/cancers15061863","article-title":"Sex differences in survival from neuroendocrine neoplasia in England 2012-2018: a retrospective, population-based study.","volume":"15","author":"White","year":"2023","journal-title":"Cancers"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u2018carcinoid\u2019: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:04:41Z","timestamp":1748361881000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000877","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}